Argyris Vassiliou - Net Worth and Insider Trading

Argyris Vassiliou Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Argyris Vassiliou owns 3 companies in total, including Kura Oncology Inc (KURA) , Aerpio Pharmaceuticals Inc (ARPO) , and Aadi Bioscience Inc (AADI) .

Click here to see the complete history of Argyris Vassiliou’s form 4 insider trades.

Insider Ownership Summary of Argyris Vassiliou

Ticker	Comapny	Transaction Date	Type of Owner
KURA	Kura Oncology Inc	2008-04-01	10 percent owner
ARPO	Aerpio Pharmaceuticals Inc	2008-04-01	10 percent owner
AADI	Aadi Bioscience Inc	2008-04-01	10 percent owner

Argyris Vassiliou Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Argyris Vassiliou Ownership Network

Ownership Network List of Argyris Vassiliou

No Data

Ownership Network Relation of Argyris Vassiliou

Argyris Vassiliou Owned Company Details

What does Kura Oncology Inc do?

Who are the key executives at Kura Oncology Inc?

Argyris Vassiliou is the 10 percent owner of Kura Oncology Inc. Other key executives at Kura Oncology Inc include Chief Legal Officer Teresa Brophy Bair , Chief Medical Officer Stephen Dale , and SVP & Finance & Accounting Thomas James Doyle .

Kura Oncology Inc (KURA) Insider Trades Summary

Over the past 18 months, Argyris Vassiliou made no insider transaction in Kura Oncology Inc (KURA). Other recent insider transactions involving Kura Oncology Inc (KURA) include a net sale of 21,208 shares made by Stephen Dale , a net sale of 4,668 shares made by Teresa Brophy Bair , and a net sale of 3,866 shares made by Thomas James Doyle .

In summary, during the past 3 months, insiders sold 2,615 shares of Kura Oncology Inc (KURA) in total and bought 0 shares, with a net sale of 2,615 shares. During the past 18 months, 126,017 shares of Kura Oncology Inc (KURA) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 76,017 shares.

Kura Oncology Inc (KURA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kura Oncology Inc Insider Transactions

No Available Data

What does Aerpio Pharmaceuticals Inc do?

Who are the key executives at Aerpio Pharmaceuticals Inc?

Argyris Vassiliou is the 10 percent owner of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .

Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerpio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aadi Bioscience Inc do?

Who are the key executives at Aadi Bioscience Inc?

Argyris Vassiliou is the 10 percent owner of Aadi Bioscience Inc. Other key executives at Aadi Bioscience Inc include director & See Remarks Neil Desai , director & Chief Executive Officer David James Lennon , and Chief Financial Officer Scott M. Giacobello .

Aadi Bioscience Inc (AADI) Insider Trades Summary

Over the past 18 months, Argyris Vassiliou made no insider transaction in Aadi Bioscience Inc (AADI). Other recent insider transactions involving Aadi Bioscience Inc (AADI) include a net sale of 584,000 shares made by Neil Desai ,

In summary, during the past 3 months, insiders sold 122,000 shares of Aadi Bioscience Inc (AADI) in total and bought 0 shares, with a net sale of 122,000 shares. During the past 18 months, 584,000 shares of Aadi Bioscience Inc (AADI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,000 shares.

Aadi Bioscience Inc (AADI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aadi Bioscience Inc Insider Transactions

No Available Data

Argyris Vassiliou Mailing Address

Above is the net worth, insider trading, and ownership report for Argyris Vassiliou. You might contact Argyris Vassiliou via mailing address: 45 10 Court Square, Floor 2, Long Island City Ny 11101.

Discussions on Argyris Vassiliou

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.